biotech stock review

Orchestra BioMed™ Announces Completion of $41 Million Financing.

November 15, 2018 Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and hypertensionFinancing structure provides for up to...

Immunomedics Chairman Buys $19 Million More in Stock.

(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132, an antibody-drug...

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage to investors...

Bradley Rotter: Cybersecurity: AI, Friend or Foe?

Applied AI Conference 2017  https://youtu.be/VcNXvqdsKMI?si=Ze_a_LHMrkb-4ksk The Applied AI Conference is a must-attend event for people who are working, researching, building, and investing in Applied Artificial Intelligence...
Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears. As posted on SeekingAlpha.
Roland Rick Perry, Biotech Stock Review

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.

“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.” On August 20th CNS-Wellness, a wholly owned...

The Artist Who Painted Facebook’s First Office Took Stock Instead of Cash — And...

Sean Parker persuaded artist David Choe to take stock instead of cash for painting the walls of Facebook's first office. Now that stock is...
zestra, biotech stock review

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for bipolar disorder,...

Latest article

Fusion Energy Starter.

VC-Funded Fusion Energy Companies "The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets. UniQure (QURE) $47 up Huge. Still Not Out Of The Woods! II. Replimune (REPL) $11.23. Gains 28% in Sympathy with...

We’re Up 360% in Six Weeks. Replimune (REPL).

That's a Gain of $604 Million, and That Ain't Bad! Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...